borderline significantP = 0.05
Although borderline significant, this was similar in hMSC-injected animals (16.4 ± 2.6%; P = 0.05).
Although borderline significant, this was similar in hMSC-injected animals (16.4 ± 2.6%; P = 0.05).
Osteogenic differentiation potential By combining the results of all differentiated donors, protocol A and C showed a trend for optimal osteogenic differentiation in hMSC ( Fig. 3C and D), and protocol C for pMSC ( Fig. 3A and B), confirming the observed microscopic data ( Table 2 ).